Spark Investment Management LLC Agios Pharmaceuticals, Inc. Transaction History

Spark Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$31.52 - $53.81 $271,229 - $463,035	-8,605 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$30.08 - $50.59 $236,699 - $398,092	-7,869 Reduced 47.77%	8,605 $410,000
Q3 2019 Nov 12, 2019	SELL	$32.4 - $49.58 $2.53 Million - $3.87 Million	-78,026 Reduced 82.57%	16,474 $533,000
Q2 2019 Aug 12, 2019	BUY	$46.17 - $68.1 $466,317 - $687,810	10,100 Added 11.97%	94,500 $4.71 Million
Q1 2019 May 07, 2019	SELL	$45.92 - $67.67 $2.35 Million - $3.46 Million	-51,200 Reduced 37.76%	84,400 $5.69 Million
Q4 2018 Feb 12, 2019	BUY	$42.73 - $76.53 $1.34 Million - $2.4 Million	31,300 Added 30.01%	135,600 $6.25 Million
Q3 2018 Nov 13, 2018	BUY	$71.67 - $91.95 $7.48 Million - $9.59 Million	104,300 New	104,300 $8.04 Million
Q1 2018 May 10, 2018	SELL	$59.83 - $86.53 $873,518 - $1.26 Million	-14,600 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$52.12 - $72.33 $1.8 Million - $2.5 Million	-34,600 Reduced 70.33%	14,600 $834,000
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $2.7 Million - $3.3 Million	49,200	49,200 $3.28 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.22B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.